Jonathan Doogan

Chief Strategy & Commercial Officer (svp) at Causeway Therapeutics

Jonathan Doogan has extensive experience in the healthcare, biotech, and pharma industries. Jonathan is currently the Chief Strategy & Commercial Officer (SVP) at Causeway Therapeutics and also serves as the Director at DDI AG, where they provide advisory, operational, and investment expertise. Jonathan has previously held leadership roles at Novartis, including Head of Customer Engagement, Solutions & Digital Innovation (Vice-President) and Chief Commercial Officer. Prior to Novartis, they served as the Head of Innovation at Amgen (Europe) and worked as a Partner and Managing Director at a-connect. Jonathan began their career at McKinsey & Company as an Associate Principal. Jonathan also has experience at Pfizer and Eli Lilly and Company, where they held various roles in product management and sales. Currently, Jonathan is a Healthcare Industry Advisor at the University of Oxford.

Jonathan Doogan attended Kent College, Canterbury from 1990 to 1994. Jonathan then pursued a MA in Law at the University of Oxford from 1994 to 1997.

Location

Zug, Switzerland

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Causeway Therapeutics

Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health. It develops novel microRNA therapies for the treatment of common musculoskeletal and age-related diseases.


Employees

1-10

Links